title: Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases.
abstract: The Santa Fe Bone Symposium is an annual meeting of healthcare professionals and clinical researchers that details the clinical relevance of advances in knowledge of skeletal diseases. The 17th Santa Fe Bone Symposium was held in Santa Fe, New Mexico, USA, on August 5-6, 2016. The program included plenary lectures, oral presentations by endocrinology fellows, meet-the-professor sessions, and panel discussions, all aimed to provide ample opportunity for interactive discussions among all participants. Symposium topics included recent developments in the translation of basic bone science to patient care, new clinical practice guidelines for postmenopausal osteoporosis, management of patients with disorders of phosphate metabolism, new and emerging treatments for rare bone diseases, strategies to enhance fracture healing, and an update on Bone Health Extension for Community Healthcare Outcomes, using a teleconferencing platform to elevate the level of knowledge of healthcare professionals in underserved communities to deliver best practice care for skeletal diseases. The highlights and important clinical messages of the 2016 Santa Fe Bone Symposium are provided herein by each of the faculty presenters.
authors.affiliation: New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA. Electronic address: mlewiecki@gmail.com.
authors.forename: E Michael
authors.initials: EM
authors.lastname: Lewiecki
authors.affiliation: Columbia University College of Physicians and Surgeons, New York, NY, USA.
authors.forename: John P
authors.initials: JP
authors.lastname: Bilezikian
authors.affiliation: UCLA Orthopaedic Center, Santa Monica, CA, USA.
authors.forename: Susan V
authors.initials: SV
authors.lastname: Bukata
authors.affiliation: Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.
authors.forename: Pauline
authors.initials: P
authors.lastname: Camacho
authors.affiliation: Mayo Clinic College of Medicine, Rochester, MN, USA.
authors.forename: Bart L
authors.initials: BL
authors.lastname: Clarke
authors.affiliation: Oregon Osteoporosis Center, Portland, OR, USA.
authors.forename: Michael R
authors.initials: MR
authors.lastname: McClung
authors.affiliation: Colorado Center for Bone Research at Centura Health, Lakewood, CO, USA.
authors.forename: Paul D
authors.initials: PD
authors.lastname: Miller
authors.affiliation: Department of Radiology and Biochemical Imaging, University of California, San Francisco, CA, USA.
authors.forename: John
authors.initials: J
authors.lastname: Shepherd
mesh_terms: D015502:Absorptiometry, Photon; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D056657:Cathepsin K / Q000037:antagonists & inhibitors; D002908:Chronic Disease; D000069448:Denosumab / Q000627:therapeutic use; D055808:Drug Discovery; D017102:Fracture Healing; D006801:Humans; D054559:Hyperphosphatemia / Q000097:blood / Q000188:drug therapy; D017674:Hypophosphatemia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D010024:Osteoporosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D058866:Osteoporotic Fractures / Q000188:drug therapy*; D044162:Parathyroid Hormone-Related Protein / Q000627:therapeutic use; D010758:Phosphorus / Q000097:blood*; D017410:Practice Guidelines as Topic; D053245:RANK Ligand / Q000378:metabolism; D035583:Rare Diseases / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D053246:Receptor Activator of Nuclear Factor-kappa B / Q000378:metabolism; D057170:Translational Research, Biomedical
chemical_list: D050071:Bone Density Conservation Agents; D044162:Parathyroid Hormone-Related Protein; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; D010758:Phosphorus; D000069448:Denosumab; C000596789:abaloparatide; D056657:Cathepsin K
keywords: DXA; ECHO; osteoporosis; phosphorus